iBio Inc. (IBIO) Financials Nov 18, 2014, 5:15 p.m
Post# of 250602
Posted On: 11/18/2014 10:42:56 PM
iBio Inc. (IBIO) Financials Nov 18, 2014, 5:15 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for iBio Inc.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 520,080 1.28M 1.01M 205,000
Cost of Goods Sold (COGS) incl. D&A 337,029 376,810 - - -
COGS excluding D&A 0 0 - - -
Depreciation & Amortization Expense 337,029 376,810 329,712 338,000 361,000
Depreciation 3,828 3,810 - 2,000 3,000
Amortization of Intangibles 333,201 373,000 - 336,000 358,000
Gross Income (337,029) 143,270 - - -
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 4.25M 9.21M 10.19M 7.34M 5.43M
Research & Development 2.52M 3.08M 4.98M 3.43M 1.9M
Other SG&A 1.73M 6.13M 5.21M 3.91M 3.53M
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.51M 3.06M (3.58M) (520,000) (1.86M)
EBIT after Unusual Expense (1.51M) (3.06M) 3.58M 520,000 1.86M
Non Operating Income/Expense 26,792 (27,381) (28,463) (60,000) 44,000
Non-Operating Interest Income 12,731 12,620 11,673 9,000 8,000
Equity in Affiliates (Pretax) 0 0 - 0 -
Interest Expense 13,109 0 0 0 0
Gross Interest Expense 13,109 0 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
Income Tax 2,400 0 0 0 0
Income Tax - Current Domestic 2,400 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic (1.82M) 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits (1.82M) 0 - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
Minority Interest Expense 0 0 0 0 0
Net Income (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
EPS (Basic) (0.22) (0.39) (0.14) (0.13) (0.06)
Basic Shares Outstanding 27.3M 30.97M 39.51M 49.38M 62.97M
EPS (Diluted) (0.22) (0.39) (0.14) (0.13) (0.06)
Diluted Shares Outstanding 27.3M 30.97M 39.51M 49.38M 62.97M
EBITDA (4.25M) (8.69M) (8.91M) (6.33M) (5.22M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for iBio Inc.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 0 520,080 1.28M 1.01M 205,000
Cost of Goods Sold (COGS) incl. D&A 337,029 376,810 - - -
COGS excluding D&A 0 0 - - -
Depreciation & Amortization Expense 337,029 376,810 329,712 338,000 361,000
Depreciation 3,828 3,810 - 2,000 3,000
Amortization of Intangibles 333,201 373,000 - 336,000 358,000
Gross Income (337,029) 143,270 - - -
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 4.25M 9.21M 10.19M 7.34M 5.43M
Research & Development 2.52M 3.08M 4.98M 3.43M 1.9M
Other SG&A 1.73M 6.13M 5.21M 3.91M 3.53M
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.51M 3.06M (3.58M) (520,000) (1.86M)
EBIT after Unusual Expense (1.51M) (3.06M) 3.58M 520,000 1.86M
Non Operating Income/Expense 26,792 (27,381) (28,463) (60,000) 44,000
Non-Operating Interest Income 12,731 12,620 11,673 9,000 8,000
Equity in Affiliates (Pretax) 0 0 - 0 -
Interest Expense 13,109 0 0 0 0
Gross Interest Expense 13,109 0 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
Income Tax 2,400 0 0 0 0
Income Tax - Current Domestic 2,400 0 - - -
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic (1.82M) 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits (1.82M) 0 - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) - - 0 0 0
Consolidated Net Income (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
Minority Interest Expense 0 0 0 0 0
Net Income (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - - 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (6.08M) (12.14M) (5.68M) (6.2M) (3.67M)
EPS (Basic) (0.22) (0.39) (0.14) (0.13) (0.06)
Basic Shares Outstanding 27.3M 30.97M 39.51M 49.38M 62.97M
EPS (Diluted) (0.22) (0.39) (0.14) (0.13) (0.06)
Diluted Shares Outstanding 27.3M 30.97M 39.51M 49.38M 62.97M
EBITDA (4.25M) (8.69M) (8.91M) (6.33M) (5.22M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼